Measuring a new biomarker in obese children with or without type 2 diabetes
Official title: Beta-Cell - Liver Interactions in Situations of Modified Beta-Cell Function: From Mice to Children
Run by University Hospital, Geneva · NCT06682481 · Data updated 2026-11-12
This study is testing a new blood marker in obese kids aged 12 to 16, with and without type 2 diabetes, to see if it can help understand how their bodies manage sugar.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 12 Years to 16 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University Hospital, Geneva Academic / other |
| Locations | 1 site (Geneva, Canton of Geneva) |
| Status | Recruiting |
| Started | November 22, 2024 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | May 18, 2026 |
| Trial ID | NCT06682481 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are obese children aged 12 to 16 years who do not have autoimmune diabetes.
✕Probably not a fit
Patients with known liver disease or those treated with certain diabetes medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to measure blood levels of 1,5-anhydroglucitol in obese children aged 12 to 16 years, both with and without type 2 diabetes. The researchers will correlate these levels with functional beta-cell mass and glucose metabolism parameters, comparing them to healthy volunteers. The goal is to validate 1,5-anhydroglucitol as a novel biomarker for assessing beta-cell function in this population. The study is conducted at the University Hospital of Geneva in collaboration with the Diabetes Center of the Faculty of Medicine, University of Geneva.
Why it matters
Potential benefit: If successful, this study could provide a new biomarker for early detection and monitoring of beta-cell dysfunction in obese children, potentially improving management of type 2 diabetes.
How similar studies have gone: Previous studies have shown correlations between 1,5-anhydroglucitol levels and diabetes progression, suggesting potential success for this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged 12 to 16 years * Obesity. Defined as a body-mass index above the 97th percentile. * Ability to give informed consent as documented by signature Exclusion Criteria: * Patients with diabetes mellitus and positive autoantibodies against islets, insulin, islet antigen 2, glutamic acid decarboxylase or Zinc transporter 8. * Patients with known liver disease (other than NAFLD) * Patients treated with an oral antidiabetic drug, glucagon-like peptide-1 analogues or insulin at the time of or less than 2 weeks prior to inclusion. * Patients treated with a drug known to affect liver function
Where it's running
-
University Hospital of Geneva
Geneva, Canton of Geneva, Switzerland Recruiting
Study contacts
- Study coordinator: Philippe Klee
- Email: philippe.klee@unige.ch
- Phone: +41 79 55 33 476
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating brain health in youth at risk for type 2 diabetes
This study is trying to see how being overweight or having blood sugar issues affects brain health in kids aged 12-17 who might be at risk for type 2 diabetes.
-
Wise Interventions to Boost Pediatric Weight Control
This study tests whether adding two quick social-psychology activities (growth mindset and self-affirmation) to a family-based weight management program helps 10–15 year-olds with obesity achieve better BMI outcomes over 12 months.
-
Effects of postpartum exercise on breastmilk composition
This study is testing how a single workout by new mothers affects the nutrients and antibodies in their breastmilk to see if it can help their babies grow healthier.
-
Vitamin D supplementation for obese children
This study is testing whether different doses of vitamin D can help obese kids and teens improve their insulin levels and body fat over six months.
-
Behavioral sleep intervention for preventing obesity in children
This study is testing whether helping children aged 6-11 from lower-income families improve their sleep with personal coaching or educational materials can prevent obesity.
-
Intervention for preschoolers' mental health and wellness
This study is testing a 16-week program that combines mindfulness activities for preschoolers and their caregivers to see if it helps improve mental health for kids from low-income families.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.